234 related articles for article (PubMed ID: 27144870)
1. Reevaluating PSA Testing Rates in the PLCO Trial.
Shoag JE; Mittal S; Hu JC
N Engl J Med; 2016 May; 374(18):1795-6. PubMed ID: 27144870
[No Abstract] [Full Text] [Related]
2. Screening for prostate cancer: the current evidence and guidelines controversy.
Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
[TBL] [Abstract][Full Text] [Related]
3. Re: Reevaluating PSA Testing Rates in the PLCO Trial.
Albers P
Eur Urol; 2017 Feb; 71(2):300. PubMed ID: 27823819
[No Abstract] [Full Text] [Related]
4. More on Reevaluating PSA Testing Rates in the PLCO Trial.
Pinsky P; Prorok P
N Engl J Med; 2016 Oct; 375(15):1500-1501. PubMed ID: 27732807
[No Abstract] [Full Text] [Related]
5. More on Reevaluating PSA Testing Rates in the PLCO Trial.
Shoag JE; Mittal S; Hu JC
N Engl J Med; 2016 Oct; 375(15):1500-1501. PubMed ID: 27732806
[No Abstract] [Full Text] [Related]
6. Re: Reevaluating PSA Testing Rates in the PLCO Trial.
Taneja SS
J Urol; 2016 Oct; 196(4):1123-5. PubMed ID: 27628793
[No Abstract] [Full Text] [Related]
7. Lethal Prostate Cancer in the PLCO Cancer Screening Trial.
Shoag J; Mittal S; Halpern JA; Scherr D; Hu JC; Barbieri CE
Eur Urol; 2016 Jul; 70(1):2-5. PubMed ID: 27166670
[TBL] [Abstract][Full Text] [Related]
8. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
9. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
Nazim SM; Raza SJ; Ather MH
J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
[No Abstract] [Full Text] [Related]
10. Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
Pinsky PF; Prorok PC; Kramer BS
N Engl J Med; 2017 Mar; 376(13):1285-1289. PubMed ID: 28355509
[No Abstract] [Full Text] [Related]
11. The Melbourne Consensus Statement on the early detection of prostate cancer.
Murphy DG; Ahlering T; Catalona WJ; Crowe H; Crowe J; Clarke N; Cooperberg M; Gillatt D; Gleave M; Loeb S; Roobol M; Sartor O; Pickles T; Wootten A; Walsh PC; Costello AJ
BJU Int; 2014 Feb; 113(2):186-8. PubMed ID: 24206066
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: Prudent practice optimizes screening outcomes.
Auvinen A
Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
[No Abstract] [Full Text] [Related]
13. New PSA guidelines discourage overscreening.
Peres J
J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
[No Abstract] [Full Text] [Related]
14. [Prostate cancer screening: Reasons of controversy].
Delporte G; Villers A; Penel N
Bull Cancer; 2018 Dec; 105(12):1111-1118. PubMed ID: 30458966
[TBL] [Abstract][Full Text] [Related]
15. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
[TBL] [Abstract][Full Text] [Related]
16. The current state of prostate-specific antigen testing.
Lewis R; Hornberger B
JAAPA; 2016 Sep; 29(9):51-3. PubMed ID: 27575906
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
[No Abstract] [Full Text] [Related]
18. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
19. Guideline of guidelines: prostate cancer screening.
Loeb S
BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
[No Abstract] [Full Text] [Related]
20. Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening.
Ito K; Oki R; Sekine Y; Arai S; Miyazawa Y; Shibata Y; Suzuki K; Kurosawa I
Int J Urol; 2019 Oct; 26(10):956-970. PubMed ID: 31183923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
